Pharmafile Logo
Pharmafocus logo
Advanced Search
Daiichi image

Daiichi Sankyo launches clotting drug Lixiana in UK

July 10, 2015
Medical Communications, Sales and Marketing Daiichi Sankyo, Lixiana, NOAC, VTE, anticoagulant, atrial fibrillation, blood clots, edoxaban, novel anticoagulant, strokes, warfarin

Daiichi Sankyo’s Lixiana has become the latest pharma offering in the class of newer oral anticoagulants in the UK.Lixiana (edoxaban) …

News
hugh-sampson-10

Allergy expert Dr Hugh Sampson joing DBV Technologies

July 9, 2015
Research and Development DBV Technologies, Viaskin

DBV Technologies has appointed Dr Hugh Sampson as its chief scientific officer. The French biotech company is developing the Viaskin peanut allergy treatment patch. Dr …

Appointment
Logos

Praluent scores positive trial results in Japan

July 9, 2015
Research and Development Japan, PCKS9, Regeneron, Sanofi, heart disease, high cholesterol, praluent

Praluent, the new heart drug from Sanofi and Regeneron, has met its primary endpoint in a Phase III study in …

News
package_of_lutera_birth_control_pills

Actavis contraceptives recalled after packaging errors

July 9, 2015
Manufacturing and Production Actavis, FDA, manufacturing, packaging, product recall, production, recalls

Actavis is voluntarily recalling more than half a million boxes of contraceptive pills in the United States due to problems …

News
Deopmed logo

Horizon attempts a hostile $3bn Depomed takeover

July 9, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Depomed, M&A, MA, acquisitions, horizon, mergers, takeover

Dublin-based specialty pharmaceutical company Horizon has launched a bid to buy Depomed for $3 billion. Horizon, a biopharma company focussed …

News
NHS Westminster

Conservative announce NHS to receive a further £8 billion by 2020

July 9, 2015
Budget, Chancellor, Chancellor of the exchequer, Conservatives, George Osborne, NHS, NHS funding, Tories, funding, government

The Conservative Government has confirmed the NHS will receive £10 billion in funding by 2020 in the Chancellor’s budget announcement.The …

News
morgan

Pegasus appoints two new members to its pharma team

July 8, 2015
Medical Communications Pegasus

The health communications consultancy Pegasus is expanding its pharma and life sciences division, with the appointment of two new members …

Appointment
Novartis image

Novartis wins US nod for new heart drug

July 8, 2015
Research and Development, Sales and Marketing Entestro, FDA, LCZ696, Novartis, ejection fraction, heart failure, reduced ejection fraction, sacubitril

The FDA has given the green light to Novartis’ new heart failure drug, six weeks ahead of the scheduled date …

News
23andme logo

23andMe targets $150 million for drug development

July 8, 2015
Research and Development 23andME, DNA, DNA testing, genetics, venture capital

The genetic testing firm 23andMe is seeking to raise $150 million in order to move into its own drug development …

News
bayer_alexander_moscho_thumbnail

European medicines group appoints Bayer’s Alex Moscho as new chair

July 7, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Alexander Moscho, EMG, European Medicines Group

Leading UK industry group the European Medicines Group (EMG) has elected Dr Alexander Moscho, the managing director of Bayer UK …

Appointment
US-EU logo

Pharma ‘paid US doctors $1.5 billion’ in 2014

July 7, 2015
Medical Communications, Sales and Marketing Sunshine Act, US, pharma

Some of the largest European drugmakers paid US doctors and teaching hospitals $1.5 billion in 2014 to participate in promotional …

News
Teva image

Teva ‘to increase Mylan bid to $43bn’

July 7, 2015
Sales and Marketing M&A, MA, Mylan, Teva, generics

Israeli drugmaker Teva is considering whether to up its bid for US rival firm Mylan, with reports that it could …

News

Prescribing in England up 55% to £9bn over a decade

July 7, 2015
Manufacturing and Production, Sales and Marketing NHS, NHSIC, drugs, health and social care information centre, net ingredient cost, prescribing

The number of drugs issued in England continues to soar, according to the latest NHS figures which show prescribing in …

News

Biogen to build billion-dollar plant in Switzerland

July 7, 2015
Manufacturing and Production Alzherimer's disease, Biogen, Biogen IDEC, MS, Switzerland, manufacturing, multiple sclerosis

Biogen plans to open a $1 billion manufacturing facility in Switzerland, to help Europe deal with the future demand for …

News

Novo Nordisk pulls Tresiba in Germany after pricing row

July 6, 2015
Manufacturing and Production, Sales and Marketing Drug pricing, Germany, Novo Nordisk, Reimbursement, Tresiba, market access

Novo Nordisk has discontinued its distribution of once-daily basal insulin Tresiba after pricing talks with the German body that represents …

News
Bayer's Alexander Moscho

Working Life: Bayer UK & Ireland’s chief executive Alexander Moscho

July 6, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Alexander Moscho, Bayer

How did you find your way into your current role?I think it started when I was young and I was …

Feature

Adam Zaeske appointed as managing director of Takeda UK and Ireland

July 6, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Adam Zaeske, Takeda

Japanese pharma firm Takeda has appointed Adam Zaeske as managing director of Takeda UK and Ireland.Zaeske has been with Takeda …

Appointment
AbbVie

NHS England approves AbbVie’s Duodopa for Parkinson’s disease

July 6, 2015
Sales and Marketing AbbVie, Duodopa, James Palmer, NHS England, PPRS, Parkinson's, Parkinson's disease, commissioning

AbbVie has been handed a boost by NHS England, who has approved the prescribing of its Parkinson’s disease treatment Duodopa …

News
Vertex logo

Vertex’s cystic fibrosis drug gets FDA approval

July 3, 2015
Research and Development, Sales and Marketing FDA, Orkambi, Vertex, cystic fibrosis, gene therapy

Vertex Pharmaceuticals cystic-fibrosis drug Orkambi, which could treat as many as 8,500 patients in the US, has been approved by …

News
Sanofi Paris HQ

Sanofi’s Toujeo approved in Japan

July 3, 2015
Manufacturing and Production, Sales and Marketing Japan, Lantus Lantus XR, Sanofi, diabetes, toujeo, type diabetes

The Ministry of Health, Labor and Welfare in Japan has given Sanofi a marketing authorisation for the diabetes drug the …

News
The Gateway to Local Adoption Series

Latest content

Study explores genomic testing approach for unexplained infertility

May 14, 2026

Celtic Renewables receives £7m to develop bio-based solvents

May 14, 2026

Synnovis and SOPHiA GENETICS expand liquid biopsy testing in NHS cancer care

May 13, 2026

MHRA to establish Northern Ireland hub for life sciences sector

May 13, 2026

Shilpa Medicare signs manufacturing deal with NXI Therapeutics

May 12, 2026